Center for Biologics Evaluation and Research (CBER)

The Center for Biologics Evaluation and Research (CBER) is part of the U.S. Food and Drug Administration (FDA). Its primary role is to ensure the safety, effectiveness, and quality of biological products, which include vaccines, blood products, and cell or gene therapies. CBER reviews and approves these products before they reach the public, monitors their use, and regulates the facilities that produce them. By doing so, CBER helps protect public health and ensures that patients receive safe and effective treatments.